Kairos Pharma Analyst Price Targets - Benzinga

Kairos Pharma Ltd

KAPAAMEX

Trade with Public

Trade with Public

$0.4735

-0.0565-10.66%

개요 뉴스 실적 전망 이벤트목표가재무 심리 지분 현황 비교 주식 보고서

Kairos Pharma Analyst Price Targets - Benzinga

Kairos Pharma Analyst Price Targets

Wall Street analyst price targets and consensus rating for Kairos Pharma (KAPA).

Price Target Range — 5 Quarters

Analyst Consensus — 4 Analysts

4Buy

Consensus RatingBuy# Analysts4Avg. Consensus PT$60

Rating Trend — Last 9 Months

Recent Analyst Actions

모든 평가 보기 →

Date	Firm	Analyst	Action	Rating Change	Price Target
Nov 19, 2025	D. Boral Capital	Jason Kolbert	Maintained	Buy	$63
Nov 4, 2025	D. Boral Capital	Jason Kolbert	Maintained	Buy	$63
Oct 20, 2025	D. Boral Capital	Jason Kolbert	Maintained	Buy	$63
Oct 7, 2025	D. Boral Capital	Jason Kolbert	Maintained	Buy	$63
Sep 19, 2025	D. Boral Capital	Jason Kolbert	Maintained	Buy	$63
Jul 16, 2025	D. Boral Capital	Jason Kolbert	Maintained	Buy	$63
Jun 4, 2025	D. Boral Capital	Jason Kolbert	Maintained	Buy	$63
Apr 17, 2025	D. Boral Capital	Jason Kolbert	Maintained	Buy	$63
Apr 3, 2025	HC Wainwright & Co.	Joseph Pantginis	Initiate	Buy	$84
Mar 31, 2025	D. Boral Capital	Jason Kolbert	Maintained	Buy	$63
Mar 27, 2025	Maxim Group	Jason McCarthy	Initiate	Buy	$28
Mar 20, 2025	D. Boral Capital	Jason Kolbert	Maintained	Buy	$63
Feb 26, 2025	D. Boral Capital	Jason Kolbert	Maintained	Buy	$63
Feb 18, 2025	D. Boral Capital	Jason Kolbert	Maintained	Buy	$63
Feb 12, 2025	D. Boral Capital	Jason Kolbert	Maintained	Buy	$63
Jan 22, 2025	D. Boral Capital	Jason Kolbert	Maintained	Buy	$63
Nov 14, 2024	D. Boral Capital	Jason Kolbert	Maintained	Buy	$63
Oct 14, 2024	EF Hutton	Jason Kolbert	Initiate	Buy	$63

Analyst Ratings News

PRO
D. Boral Capital Maintains Buy on Kairos Pharma, Maintains $9 Price Target

D. Boral Capital analyst Jason Kolbert maintains Kairos Pharma (AMEX:KAPA) with a Buy and maintains $9 price target.

Benzinga Newsdesk

PRO
D. Boral Capital Maintains Buy on Kairos Pharma, Maintains $9 Price Target

D. Boral Capital analyst Jason Kolbert maintains Kairos Pharma (AMEX:KAPA) with a Buy and maintains $9 price target.

Benzinga Newsdesk

PRO
D. Boral Capital Maintains Buy on Kairos Pharma, Maintains $9 Price Target

D. Boral Capital analyst Jason Kolbert maintains Kairos Pharma (AMEX:KAPA) with a Buy and maintains $9 price target.

Benzinga Newsdesk

PRO
D. Boral Capital Maintains Buy on Kairos Pharma, Maintains $9 Price Target

D. Boral Capital analyst Jason Kolbert maintains Kairos Pharma (AMEX:KAPA) with a Buy and maintains $9 price target.

Benzinga Newsdesk

PRO
D. Boral Capital Maintains Buy on Kairos Pharma, Maintains $9 Price Target

D. Boral Capital analyst Jason Kolbert maintains Kairos Pharma (AMEX:KAPA) with a Buy and maintains $9 price target.

Benzinga Newsdesk

PRO
D. Boral Capital Maintains Buy on Kairos Pharma, Maintains $9 Price Target

D. Boral Capital analyst Jason Kolbert maintains Kairos Pharma (AMEX:KAPA) with a Buy and maintains $9 price target.

Benzinga Newsdesk